Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial.
Saved in:
| Title: | Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trial. |
|---|---|
| Authors: | McGree, J. M.1 (AUTHOR) james.mcgree@qut.edu.au, Hockham, C.2,3 (AUTHOR), Kotwal, S.2,4 (AUTHOR), Wilcox, A.2,5 (AUTHOR), Bassi, A.6 (AUTHOR), Pollock, C.7,8 (AUTHOR), Burrell, L. M.9 (AUTHOR), Snelling, T.10,11 (AUTHOR), Jha, V.2,6 (AUTHOR), Jardine, M.2,5,12 (AUTHOR), Jones, M.10 (AUTHOR), CLARITY Trial Steering Committee (CORPORATE AUTHOR) |
| Source: | Trials. 4/27/2022, Vol. 23 Issue 1, p1-18. 18p. 1 Diagram, 5 Charts, 5 Graphs. |
| Database: | Academic Search Ultimate |
| ISSN: | 17456215 |
|---|---|
| DOI: | 10.1186/s13063-022-06167-2 |
